CureApp Announces Results from World’s First Randomized Control Study for Digital Therapeutic Smoking Cessation App
Tokyo, Japan – May 30, 2019 – Results
from the world’s first randomized control study to examine digital
therapeutic smoking cessation programs were presented on May 20th at
the American Thoracic Society International Conference. The findings demonstrate
that CureApp’s nicotine dependence treatment app resulted in an improvement in continuous
abstinence rate (CAR) compared to a control group over multiple time points.
Kohta
Satake, M.D., M.B.A., M.P.H., Chief Executive Officer of CureApp, Inc.
and a respiratory specialized physician says, "Healthcare professionals
are challenged to help patients fight against the psychological nicotine
addiction alone between clinical visits. CureApp’s digital therapeutics approach is a breakthrough in bridging
the gap between clinical visits providing daily support to the patients. We are
striving for regulatory and reimbursement approval to deliver the solution as
soon as possible.”
The CureApp
solution delivers information and educational material through an app that is
conveniently on the patient’s smartphone, together with a Carbon Monoxide (CO)
monitor for tracking their progress, and a web interface for physicians.
CureApp’s system is the first such program to undergo the rigorous testing of
Phase III clinical trials. With this confirmation of its efficacy, CureApp’s
goal is to use this data to obtain regulatory approval and health insurance
coverage in Japan and to expand globally in multiple countries including the
United States.
Nicotine
dependence
Nicotine
dependence is a type of drug dependence; its intensity has been reported to be
comparable to that of heroin and cocaine*1. Smoking is the Number 1
leading cause of preventable death in Japan*2 and the US*3.
The
Clinical Trial
CureApp’s
Phase III clinical trial in Japan was completed in December 2018, and the
results were presented at the America Thoracic Society International
Conference, ATS 2019 by Dr. Hiroki Tateno, Division of Pulmonary Medicine,
Department of Medicine, Keio University, School of Medicine.
The
continuous abstinence rate (CAR)* at 9 to 24 weeks, the primary endpoint to
verify the efficacy of the CureApp Smoking Cessation, was statistically
significantly higher in the trial treatment group than the control group,
demonstrating that the CureApp Smoking Cessation contributed to continuous
smoking abstinence.
*Continuous abstinence rates at 9 to 24 weeks: Rates of patients
who continuously abstained from smoking at 9 to 24 weeks after the start of
smoking cessation treatment.
The clinical
trial was a multicenter, randomized, prospective, two-group comparative study
of the efficacy and safety of the CureApp Smoking Cessation in combination with
the standard smoking cessation treatment program in patients with nicotine
dependence who visited a smoking cessation clinic. In this clinical trial, the CureApp
Smoking Cessation (smartphone application for patients, portable CO checker for
patients, and web-based application for physicians) or control device (the
control group application) was used for 24 weeks in addition to the standard
smoking cessation program.
Of the 584
patients who participated in this trial, 285 patients were assigned to the
treatment group using the application for nicotine dependence treatment, 287 patients
were assigned to the control group using the control application. Total of 572 patient
data was used for analysis. The main evaluation item is "Continuous
Abstinence Rate (CAR) at Week 9-24".
Efficacy
The CAR at
9 to 24 weeks, the primary endpoint, was 63.9% (182/285 subjects) in the trial
treatment group and 50.5% (145/287) in the control group. The CAR was higher by
13.4% in the trial treatment group, showing a statistically significant
difference (95% confidence interval, 1.239-2.424; P = 0.001), with an odds
ratio of 1.73. The result demonstrates that the CureApp Smoking Cessation
contributed to continuous smoking abstinence.
*1 Source: Kinen no Igaku (Medicine of Smoking Cessation), Japan Medical
Association
*2 Source: Adult Mortality Attributable to Preventable
Risk Factors for Noncommunicable Diseases and Injuries in Japan in 2007, the
Ministry of Health, Labour and Welfare
*3 Source: Health
Effects of Cigarette Smoking, CDC
<https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm>
<https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm>
About CureApp
CureApp,
Inc., a MedTech venture company, engages in research and development to create
and market medical programs and devices for disease treatment with advanced
software technology and medical evidence. Its pioneering work in digital
therapeutics will bring new solutions for a variety of conditions, including nicotine
addiction, diabetes, and hypertension amongst others.
Currently,
CureApp is jointly developing a nicotine dependence treatment solution with the
Division of Pulmonary Medicine, Keio University, School of Medicine (clinical
trial completed), a non-alcoholic steatohepatitis (NASH) treatment solution
with the University of Tokyo Hospital (clinical trial in progress), and a
hypertension treatment solution with Cardiovascular Medicine, Jichi Medical
University (clinical trial in progress).
By
leveraging the knowledge and findings accumulated in the development of these
treatment applications for medical institutions, CureApp provides mobile health
programs for private corporations and health insurance associations, including
the "ascure Smoking Cessation Program" and "ascure STEPS Lifestyle
Habit Improvement Program." CureApp plans to expand these and other
digital therapeutic solutions from Japan to the global market. For more information visit, https://cureapp.co.jp/en/.
Contact:
For US media
Joy Scott, CEO, Scott Public Relations
E-mail: Joy@scottpublicrelations.com
Phone: 818.610.0270
For media from other countries
Nanako Daime, Public Relations Manager, CureApp, Inc.
E-mail: nanako.daime@cureapp.jp
This is my testimony on how i was cured by Dr Idahosa, i am Juliet Pius i had Hiv Disease for 2years and i tried all means to treat my self but no doctor could help me cure the Hiv permanently i even took some drugs that was prescribe to me by many doctors but none could work i felt it was going to stay permanently since i could not cure my self until one day i was browsing through the internet i saw different testimony with different people on how they were cured from the disease by Dr Idahosa i never wanted to try because i knew anything done with internet were always scam but because of the pain i have i gave it a try and email him and he replied back i told him my problem he prepared a portion and send it to me which he instructed i should take morning and night i did it constantly and suddenly i started having change in me, so my brothers and sisters am glad to say Dr Idahosa has cured me from my Hiv disease he can cure any disease or sickness if you give him a try, you can email him today at; (dridahosasolutioncenter@gmail.com) or whatssap him +2348134261542 he is a nice man.
ReplyDeleteMy name is Samuel, I was in love with my wife and we were married for eight years with a son his is Liam,I loved my wife so much she had access to all my bank account and even my cash app which my accountant agreed to and said it was a great idea, then it took my wife and my accountant two month to get hold of all my properties,all accounts but I had a cash app which they knew nothing about,I was thrown out of my own house was sleeping in a hotel for weeks she also took possession of my son could only see him once a week then I found out she was in love with my accountant all these while so I went online and I came across a Russian private investigator who help me get all my properties and my accounts back even my company back how he did these I don’t know but I gave all the information he asked for and followed all his instructions and now I’m happy my life’s better now.
ReplyDeleteThanks to premiumhackservices@gmail.com
I just said I should share my own story here
Thank you
HAVE YOU LOST YOUR MONEY TO BINARY OPTION SCAM OR ANY ONLINE SCAM WHATSOEVER?.DO YOUR DESIRE CREDIT REPAIR[EQUIFAX, EXPERIAN, TRANSUNION? WELL, YOU HAVE FOUND REDEMPTION IN ASORE CORP.
ReplyDeleteAsore Corp is a group of multinational Hacker's, an affiliate of Evil Corp. We make sure by all means necessary that our clients get the best of services on a��PAYMENT AFTER JOB IS DONE BASIS✅. Rather than send money and trust a criminal to fulfill your deal, you can make sure the job is done before WORKMANSHIP is paid for. You'll get excellent customer service.
That's a 100% guarantee. Our Cyber security Technicians are on standby 24/7 to receive your job requests.
⚠️ BEWARE OF FRAUDSTARS looking to hoax.
if you have been a VICTIM, contact : ✉️cyberprecinct@gmail.com for directives.
Here, it's always a win for you.
��OUR SERVICES��
➡️Binary Option funds recovery
➡️Social media hack
➡️Recovery of loan scam
➡️Credit repair (Equifax,Experian,Transunion)
➡️Email hack
➡️College score upgrade
➡️Android & iPhone Hack
➡️Website design
➡️Website hack
And lots more.
DISCLAIMER: Asore Cyber Corp accepts no responsibility for any information,previously given to anybody by clients on as regarding the job. Asore Cyber Corp will not distribute contact information collected on any hacking job other than in the Asore corps Hacker's listings themselves, and will not sell contact information to third parties.
CONTACT INFO:
�� asorehackcorp@gmail.com
cyberprecinct@gmail.com
Copyright ©️
Asore Cyber Corp 2021.
All rights reserved.